TheraPsil – Some Frequently Asked Questions

It has been a busy few months at TheraPsil and we will be launching some press releases and new information shortly, so be sure to check back soon to stay up to date! Before we highlight our next press release, we want to share some general information about Therapsil and answers to frequently asked questions about psilocybin and psilocybin-assisted psychotherapy.

Current research, in the field of psychedelics, highlights the benefits of psychedelic-assisted psychotherapy, which is appealing to many practitioners and prospective patients. For people who are unfamiliar with the research, this topic may be a new and intriguing prospect that requires further investigation before reaching a judgment. Wherever you are in your evaluation of psychedelics as therapeutics, we hope that this article helps answer some of the frequently asked questions (FAQs) that you may have about psilocybin-assisted therapy.

What is TheraPsil?

Therapsil is a coalition of people dedicated to fighting for the right of Canadians facing end-of-life distress to have legal access to therapeutic psychedelics. Our main focus at this time is to fight for the right of Canadians with terminal illness to access psilocybin-assisted psychotherapy. Although we hope to eventually provide psilocybin-assisted psychotherapy to all Canadians, we have decided to currently limit our treatment scope to end-of-life distress for patients with palliative diagnosis as this treatment has the most rigorous scientific evidence demonstrating therapeutic efficacy and safety.

What is Psilocybin?

Psilocybin is a compound in mushrooms that creates psychoactive and psychedelic effects, which may include alterations in sensation, cognition, and emotion. Psilocybin can be synthesized to better ensure the purity, potency, and accuracy of doses. Researchers use this synthetic form in their clinical trials.

What is psilocybin-assisted psychotherapy?

Psilocybin-assisted psychotherapy refers to the professionally guided use of psilocybin in combination with psychotherapy, and differs greatly from the recreational use of psychedelics. Psilocybin-assisted psychotherapy involves a rigorous and clinically tested treatment protocol that encompasses careful medical oversight of the treatment session, as well as pre- and post-psychotherapy sessions that help prepare an individual for lasting healing.

How can psilocybin help those facing end-of-life distress?

Research shows that psilocybin can have profoundly positive effects on people facing the end of life. Doses of psilocybin, accompanied by psychotherapy, can help reduce the depression, anxiety, and hopelessness that is often associated with the end-of-life experience. This treatment can also increase a sense of spiritual connectedness and meaning in life, while at the same time reducing a desire to hasten death and the existential anxiety that is associated with facing the end of life.

What are the dangers of psilocybin-assisted psychotherapy?

As with all treatments, there are contraindications and risks. However, the medical literature suggests that psilocybin-assisted therapy is very safe and effective in comparison to other treatments. The safety profile of psilocybin-assisted psychotherapy is different from the recreational use of psychedelics as the treatment setting is carefully prepared, the psychotherapist works to prepare the patient, and monitor the session. Research also shows that psilocybin is not addictive. Rather, psilocybin is actually anti-addictive, meaning that individuals who consume psilocybin tend to reduce their consumption of other substances.

Is psilocybin-assisted psychotherapy illegal?

Yes. TheraPsil exists because patients in critical condition who would benefit from a safe, effective, and proven therapy like psilocybin-assisted therapy are not able to access it. We are working to change this, so that patients can access the care they need.

Who can access this treatment?

At this time we are working towards legal access for individuals with a palliative diagnosis and end-of-life distress. If you or someone you know are interested in legal access to psilocybin-assisted psychotherapy, please get in touch with us here.

How can I learn more or get in touch with TheraPsil?

If you’re a patient, get in touch here.

If you’re a medical care provider, get in touch via info@therapsil.ca If you’re media, please email info@therapsil.ca If you are interested in following us and supporting our goals, please send an email to donations@therapsil.ca

Or follow us on social media:

Facebook Twitter Instagram

Thank you for supporting Therapsil, we look forward to sharing more updates with you soon!

#psilocybin #therapsil #psychedelic #psychotherapy #palliativecare #righttotry #access #treatment